Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 1
2008 2
2009 1
2012 1
2013 1
2015 1
2017 1
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Estimands-What they are and why they are important for pharmacometricians.
Akacha M, Bartels C, Bornkamp B, Bretz F, Coello N, Dumortier T, Looby M, Sander O, Schmidli H, Steimer JL, Vong C. Akacha M, et al. Among authors: dumortier t. CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):279-282. doi: 10.1002/psp4.12617. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33951755 Free PMC article. No abstract available.
Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes.
Klein A, Loupy A, Stegall M, Helanterä I, Kosinski L, Frey E, Aubert O, Divard G, Newell K, Meier-Kriesche HU, Mannon RB, Dumortier T, Aggarwal V, Podichetty JT, O'Doherty I, Gaber AO, Fitzsimmons WE; Transplant Therapeutics Consortium. Klein A, et al. Among authors: dumortier t. Am J Transplant. 2023 Oct;23(10):1496-1506. doi: 10.1016/j.ajt.2023.04.018. Epub 2023 Sep 18. Am J Transplant. 2023. PMID: 37735044
Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes.
Klein A, Loupy A, Stegall M, Helanterä I, Kosinski L, Frey E, Aubert O, Divard G, Newell K, Meier-Kriesche HU, Mannon R, Dumortier T, Aggarwal V, Podichetty JT, O'Doherty I, Gaber AO, Fitzsimmons WE. Klein A, et al. Among authors: dumortier t. Transpl Int. 2023 Sep 25;36:11951. doi: 10.3389/ti.2023.11951. eCollection 2023. Transpl Int. 2023. PMID: 37822449 Free PMC article.
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).
Musuamba FT, Manolis E, Holford N, Cheung S, Friberg LE, Ogungbenro K, Posch M, Yates J, Berry S, Thomas N, Corriol-Rohou S, Bornkamp B, Bretz F, Hooker AC, Van der Graaf PH, Standing JF, Hay J, Cole S, Gigante V, Karlsson K, Dumortier T, Benda N, Serone F, Das S, Brochot A, Ehmann F, Hemmings R, Rusten IS. Musuamba FT, et al. Among authors: dumortier t. CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):418-429. doi: 10.1002/psp4.12196. Epub 2017 Jul 19. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28722322 Free PMC article.
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.
Skvara H, Dawid M, Kleyn E, Wolff B, Meingassner JG, Knight H, Dumortier T, Kopp T, Fallahi N, Stary G, Burkhart C, Grenet O, Wagner J, Hijazi Y, Morris RE, McGeown C, Rordorf C, Griffiths CE, Stingl G, Jung T. Skvara H, et al. Among authors: dumortier t. J Clin Invest. 2008 Sep;118(9):3151-9. doi: 10.1172/JCI35636. J Clin Invest. 2008. PMID: 18688284 Free PMC article. Clinical Trial.
16 results